Summary Studies were performed to determine whether localized treatment of subcutaneously growing Lewis Lung Carcinoma (LLC) in C57BL/6 mice with porphyrin photodynamic therapy (PDT) affects the formation of distant metastases. Treatments consisted of a 10mgkg-' dose of dihematoporphyrin-ether (Photofrin 11) followed 24h later by local tumour irradiation with 630nm red light. Total doses of light ranged from 0-500J cm-2 and the irradiance of delivered light was 150mWcm-2. Primary LLC tumours were treated at a volume of 25-30 mm3, and lung metastases were determined 21 days following transplantation. Mice exposed to PDT treatment which produced either partial or complete local tumoricidal responses had significantly decreased numbers of metastatic lung colonies compared to controls. In addition, PDT treated mice had equal or less metastatic lung colonies than comparable mice treated with local surgical excision of the primary LLC lesion. These results indicate that local PDT does not enhance metastatic spread of LLC following either curative or noncurative treatments.
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Photodynamic therapy (PDT) continues to show promise in early stage malignancies combined with the continued the clinical treatment of solid tumours (Dougherty et Dougherty, 1984) . Preferential PDT have led us to examine the relationship between PDT uptake and retention of haematoporphyrin derivative or its and induction of tumour metastasis. The objective of our active component di-haematoporphyrin ether (photofrin II) study was therefore to determine whether localized PDT in malignant tissue compared to surrounding normal tissue treatments in C57BL/6 mice with subcutaneous Lewis lung (Gomer & Dougherty, 1979; Little et al., 1984) , together carcinoma affected tumour dissemination. with the efficient photochemical production of cytotoxic singlet oxygen by these compounds (Weishaupt et al., 1976) account for the efficacy of PDT. The advancement in Materials and methods clinically available lasers and fiberoptic light delivery systems has also enhanced the selectivity with which tumour localized Drugs porphyrins can be activated Moore, Photofrin II (dihematoporphyrin-ether) Benson, 1985) . Preliminary clinical PDT results also remain o 1 encouraging for treating colorectal, ocular, brain, administration in animals receiving a 50 mg kg-dose. gynaecologic, oesophageal, head and neck, and cutaneous neoplasms (Herrera-Ornelas et al., 1986; Bruce, 1984; Cheng Animal and tumour model et al., 1986; McCaughan et al., 1985; Wile et al., 1984; Tse et Female C57BL/6 mice were obtained from Jackson al., 1984) .
Laboratories, Bar Harbor, Maine and were entered into The expanding use of PDT in the clinic dictates that studies at 7 to 9 weeks of age. The Lewis lung carcinoma studies be performed which will examine potential limitations (LLC) was obtained from the Division of Cancer Treatment and/or side effects of this procedure. At the cellular level it Tumor Repository, NCI-Frederick Cancer Research Facility has been well documented that PDT can induce damage to and was grown as a subcutaneous mass for serial passage the plasma membrane, cytoplasmic organelles and to nuclear and tumour cell transplantation. Single cell suspensions of structures (Moan, 1986) . While PDT can cause various types LLC were obtained by passing minced tumour pieces of nuclear damage, studies indicate that PDT does not through 19, 22 and 25 gauge needles. Viability of tumour induce mutagenic (Gomer et al., 1983) or carcinogenic cells (as determined by trypan blue exclusion) was always changes in mammalian cells (Gomer, unpublished results Dougherty, 1984) . However, an between 25-30 mm3 were used in PDT and surgery increasing number of studies continue to demonstrate that experiments. direct vascular damage is induced by PDT (Selman et al., exposed to the light. Red light was generated from an argon implantation, had no effect on the growth rate of the pumped dye laser (Spectra Physics, Mountain View, CA). A tumour (data not shown). Mice with tumours measuring 400 gm diameter quartz fiberoptic cable was interfaced to the between 25-30 mm3 (4-6 days following transplantation) output of a dye laser and a microlens was attached to the were utilized in PDT treatments. distal tip of the fiber for light delivery. The wavelength of Figure 2 shows the number of metastatic lung colonies delivered light (630nm) was measured with a spectroscope observed in mice with subcutaneously growing LLC as a (Cooper Lasersonics, Santa Clara, CA) and the light power function of time following transplantation. Metastatic lung was determined using a power meter (Coherent Radiation, colonies were first observed 10 days following tumour Palo Alto, CA). The irradiance or dose rate of delivered light transplantation. Between 50-70 metastatic colonies per lung was kept at 150 mWcm-2 and the total light dose ranged were observed by day 21. The administration of Photofrin II from 0-500 J cm-2. All animals were restrained with tape five days following transplantation had no effect on the during PDT treatment.
number of metastatic lung colonies which were subsequently Surgical excision of the primary LLC was performed in observed in the transplanted mice. All studies related to certain experiments. In these procedures, animals were first quantification of metastatic lung colonies were performed 21 anaesthetized using an i.p. injection of sodium pentobarbital days following the s. Table I shows the effect of PDT or surgery on the Figure 1 shows the growth curve for LLC following subincidence of metastatic lung colonies in tumour bearing mice cutaneous transplantation of 106 cells to the flank of when treatments were started when the primary flank lesion C57BL/6 mice. Following a short lag period, the tumour measured 25-30 mm3. Table II is a subpopulation of Table I and shows the Days following transplantation effect of PDT or surgery on the incidence of metastatic lung Figure 1 Growth rate of LLC tumour following transplantation colonies in tumour bearing mice when all treatments were of 106 LLC cells to the hind flank of C57BL/6 mice. Tumour started 5 days following tumour implantation. In this set of volumes were calculated using the formula a xb x cx /6 and experiments, all mice treated with 100 or 200 Jcm-2 of PDT points represent the means of 12 individual tumours.
had only partial responses. The number of metastatic lung colonies for mice with complete responses were similar to responses, the combination of PDT and surgery induced a those shown in Table I but in this case there was no decreased number of metastatic lung colonies compared to statistical significant difference between surgery and PDT either surgery alone (performed on either day 5 or day 6) or treatment. No conclusion can be made for the 400 Jcm 2 Photofrin II and surgery. PDT dose since only two mice had complete responses. Table IV documents the incidence of metastatic lung Table III shows the incidence of metastatic lung colonies colonies in C57BL/6 mice when localized PDT preceeded in LLC bearing mice when PDT was followed by surgery.
LLC transplantation. PDT delivered 24 h prior to LLC For these experiments, 200 Jcm-2 of PDT was used and this transplantation had no effect on subsequent induction of dose of PDT by itself did not induce any complete responses. metastatic lung colonies. Light doses ranged from 100-The combination of PDT on day 5 and surgery on day 6 400 Jcm 2 and the left hind limb was used for PDT resulted in 8 mice having a partial response and 11 mice exposure while the right hind limb was used for tumour cell having a complete response. For mice with complete transplantation. Contralateral legs were used for this set of There is no evidence from the limited number of clinical complete local tumour responses were either comparable to PDT studies that this modality induces an increase in the or lower than that observed in mice treated by local surgical metastatic rate or potential of malignant tumours. However, excision of the tumour. Treatment of tumour-bearing mice there are similarities between PDT and hyperthermia in that with Photofrin II alone or light treatment alone, as well as both procedures can induce significant damage to the PDT delivered to mice prior to LLC transplantation had no tumour vasculature (Star et al., 1986; Berenbaum et al., effect on local tumour growth or subsequent lung metastasis. 1986; Hahn, 1982; Eddy, 1980) . Direct trauma or damage to While extrapolation of in vivo data to possible clinical effects a primary tumour may cause an increase in the number of is not possible, it would appear that PDT will not induce tumour cells released into the circulation (Hill & Denekamp, significant side-effects related to metastatic spread of 1982), although this process may not always induce malignant tumours. metastasis (Salisbury, 1975) . In the case of hyperthermia, Mice with subcutaneously growing LLC develop there still remains a controversy related to its role in the pulmonary metastases in a reproducible manner. In addition, spread of metastasis (Hahn, 1982; Hill & Denekamp, 1982;  the LLC tumour has not been observed to regress Oda et al., 1985; Yerulshalmi, 1970; Hahn et at., 1979) . The spontaneously (Yerushalmi, 1976) , and has been reported to majority of evidence suggests that localized hyperthermia be responsive to local PDT treatment (Cowled & Forbes, does not effect metastatic spread, whereas total body 1985). The LLC tumour model has also been used to study hyperthermia appears to increase the incidence of metastatic metastatic spread following local and whole body hyperspread. Stress induced by surgery is also suggested to play a thermia (Oda et at., 1986; Yerushalmi, 1976) ., 1984) . The results of our study indicate cytotoxic drugs (Stahl et at., 1985) and anaesthetics (Shapiro et al., 1981) . Our study was designed to utilize the LLC tumour model to specifically examine the role of localized PDT in the induction of metastases. It is of interest to note that relatively high doses of PDT were required for local tumour control during the 2 week period between treatment and sacrifice of animals. Partial responses (or tumour recurrences) developed in 13 out of 18 mice receiving a 10mg kg-I dose of Photofrin II and a 400 J cm-2 light dose (Table 1) . Eight out of 14 mice treated with PhotofrinII and a 500 Jcm-2 dose of light also had recurrences within the 2 week period. The high degree of resistance of the LLC to PDT is probably not due to tumour tissue hypoxia since the LLC has been shown to be sensitive to ionizing radiation (Shipley et al., 1975; Lvovsky et al., 1985) . Skin pigmentation and light attenuation may play a role in the in vivo PDT resistance observed in the LLC.
Recent studies have shown that PDT can induce systemic immunosuppression related to inhibition of contact hypersensitivity of dinitrofluorobenzene (Elmets & Bowen, 1986) . The immunosuppression induced by PDT may be mediated by activation of the complement system Lim et al., 1985) . We have observed a transient decrease in splenic natural killer (NK) cell activity following localized PDT in mice (Gomer et al., 1986) . Therefore, while PDT does not enhance metastatic spread in an experimental animal model, it does appear as though this modality can induce immunosuppression related to both T cells (documented in hypersensitivity reactions) and NK cells. However, localized PDT delivered to mice prior to LLC transplantation did not effect either the rate or quantity of subsequent metastatic lung colonies.
In summary, the documented side-effects related to PDT continue to be restricted to transient skin photosensitization. The current study indicates that local PDT does not enhance the spread of tumour metastasis. Additional investigations related to this area would appear warranted in view of both the vascular and immunological action of PDT. However, since PDT has been shown to be an effective tumoricidal procedure, the results of this study would support the continued clinical examination of PDT in the treatment of both advanced as well as early stage malignancies.
